NCT03541551View on ClinicalTrials.gov

Ologen® Collagen Matrix in Patients With Primary Congenital Glaucoma Undergoing Trabeculectomy

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 13, 2018

Primary Completion Date

September 1, 2019

Study Completion Date

September 1, 2019

Conditions

Primary Congenital GlaucomaDevelopmental GlaucomaInfantile Glaucoma

Interventions

PROCEDURE

CTT with ologen® Collagen Matrix

ologen® Collagen Matrix approved by Indian health authority with registration numberof MD-1517 will be provided by Aeon Ajanta India Pvt. Ltd. free of cost for this clinical research only.

PROCEDURE

Trab Trab

combined trabeculotomy with trabeculectomy

Trial Locations (1)

500034

Charitha, Hyderabad

All Listed Sponsors

lead

L.V. Prasad Eye Institute

OTHER

NCT03541551 - Ologen® Collagen Matrix in Patients With Primary Congenital Glaucoma Undergoing Trabeculectomy | Biotech Hunter | Biotech Hunter